212 related articles for article (PubMed ID: 12651070)
1. Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 alleles.
Lacey SF; Villacres MC; La Rosa C; Wang Z; Longmate J; Martinez J; Brewer JC; Mekhoubad S; Maas R; Leedom JM; Forman SJ; Zaia JA; Diamond DJ
Hum Immunol; 2003 Apr; 64(4):440-52. PubMed ID: 12651070
[TBL] [Abstract][Full Text] [Related]
2. The immunodominant CD8 T cell response to the human cytomegalovirus tegument phosphoprotein pp65(495-503) epitope critically depends on CD4 T cell help in vaccinated HLA-A*0201 transgenic mice.
Reiser M; Wieland A; Plachter B; Mertens T; Greiner J; Schirmbeck R
J Immunol; 2011 Sep; 187(5):2172-80. PubMed ID: 21810614
[TBL] [Abstract][Full Text] [Related]
3. The matrix protein pp65(341-350): a peptide that induces ex vivo stimulation and in vitro expansion of CMV-specific CD8+ T cells in subjects bearing either HLA-A*2402 or A*0101 allele.
Provenzano M; Lim JB; Mocellin S; Monsurro V; Bettinotti M; Marincola FM; Stroncek DF
Transfusion; 2003 Nov; 43(11):1567-74. PubMed ID: 14617317
[TBL] [Abstract][Full Text] [Related]
4. Identification of immune dominant cytomegalovirus epitopes using quantitative real-time polymerase chain reactions to measure interferon-gamma production by peptide-stimulated peripheral blood mononuclear cells.
Provenzano M; Mocellin S; Bettinotti M; Preuss J; Monsurrò V; Marincola FM; Stroncek D
J Immunother; 2002; 25(4):342-51. PubMed ID: 12142557
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel CTL epitopes of CMV-pp65 presented by a variety of HLA alleles.
Kondo E; Akatsuka Y; Kuzushima K; Tsujimura K; Asakura S; Tajima K; Kagami Y; Kodera Y; Tanimoto M; Morishima Y; Takahashi T
Blood; 2004 Jan; 103(2):630-8. PubMed ID: 12947002
[TBL] [Abstract][Full Text] [Related]
6. Soluble recombinant CMVpp65 spanning multiple HLA alleles for reconstitution of antiviral CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation.
Paine A; Oelke M; Tischer S; Heuft HG; Blasczyk R; Eiz-Vesper B
J Immunother; 2010 Jan; 33(1):60-72. PubMed ID: 19952955
[TBL] [Abstract][Full Text] [Related]
7. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
[TBL] [Abstract][Full Text] [Related]
8. Identification of T cell epitopes by the use of rapidly generated mRNA fragments.
Britten CM; Meyer RG; Graf C; Huber C; Wölfel T
J Immunol Methods; 2005 Apr; 299(1-2):165-75. PubMed ID: 15914199
[TBL] [Abstract][Full Text] [Related]
9. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.
Wills MR; Carmichael AJ; Mynard K; Jin X; Weekes MP; Plachter B; Sissons JG
J Virol; 1996 Nov; 70(11):7569-79. PubMed ID: 8892876
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.
Vaz-Santiago J; Lulé J; Rohrlich P; Jacquier C; Gibert N; Le Roy E; Betbeder D; Davignon JL; Davrinche C
J Virol; 2001 Sep; 75(17):7840-7. PubMed ID: 11483727
[TBL] [Abstract][Full Text] [Related]
11. Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8(+) T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay.
Kuzushima K; Hayashi N; Kimura H; Tsurumi T
Blood; 2001 Sep; 98(6):1872-81. PubMed ID: 11535524
[TBL] [Abstract][Full Text] [Related]
12. Identification of HLA-A24-restricted CTL epitope encoded by the matrix protein pp65 of human cytomegalovirus.
Akiyama Y; Maruyama K; Mochizuki T; Sasaki K; Takaue Y; Yamaguchi K
Immunol Lett; 2002 Aug; 83(1):21-30. PubMed ID: 12057851
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus-specific CD8(+) T cells targeting different HLA/peptide combinations correlate with protection but at different threshold frequencies.
Giest S; Grace S; Senegaglia AC; Pasquini R; Gonzalo-Daganzo RM; Fernández MN; Mackinnon S; Madrigal JA; Travers PJ
Br J Haematol; 2010 Jan; 148(2):311-22. PubMed ID: 20095088
[TBL] [Abstract][Full Text] [Related]
14. Identification of HLA-A33-restricted CMV pp65 epitopes as common targets for CD8(+) CMV-specific cytotoxic T lymphocytes.
Lim JB; Provenzano M; Kwon OH; Bettinotti M; Caruccio L; Nagorsen D; Stroncek D
Exp Hematol; 2006 Mar; 34(3):296-307. PubMed ID: 16543064
[TBL] [Abstract][Full Text] [Related]
15. Effective treatment of refractory CMV reactivation after allogeneic stem cell transplantation with in vitro-generated CMV pp65-specific CD8+ T-cell lines.
Meij P; Jedema I; Zandvliet ML; van der Heiden PL; van de Meent M; van Egmond HM; van Liempt E; Hoogstraten C; Kruithof S; Veld S; Marijt EW; von dem Borne PA; Lankester AC; Halkes CJ; Falkenburg JH
J Immunother; 2012 Oct; 35(8):621-8. PubMed ID: 22996368
[TBL] [Abstract][Full Text] [Related]
16. Identification of three HLA-A*0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus.
Solache A; Morgan CL; Dodi AI; Morte C; Scott I; Baboonian C; Zal B; Goldman J; Grundy JE; Madrigal JA
J Immunol; 1999 Nov; 163(10):5512-8. PubMed ID: 10553078
[TBL] [Abstract][Full Text] [Related]
17. Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection.
Gratama JW; van Esser JW; Lamers CH; Tournay C; Löwenberg B; Bolhuis RL; Cornelissen JJ
Blood; 2001 Sep; 98(5):1358-64. PubMed ID: 11520783
[TBL] [Abstract][Full Text] [Related]
18. Purification of Ag-specific T lymphocytes after direct peripheral blood mononuclear cell stimulation followed by CD25 selection. I. Application to CD4(+) or CD8(+) cytomegalovirus phosphoprotein pp65 epitope determination.
Gallot G; Vivien R; Ibisch C; Lulé J; Davrinche C; Gaschet J; Vié H
J Immunol; 2001 Oct; 167(8):4196-206. PubMed ID: 11591740
[TBL] [Abstract][Full Text] [Related]
19. Identification of the HLA-A24 peptide epitope within cytomegalovirus protein pp65 recognized by CMV-specific cytotoxic T lymphocytes.
Masuoka M; Yoshimuta T; Hamada M; Okamoto M; Fumimori T; Honda J; Oizumi K; Itoh K
Viral Immunol; 2001; 14(4):369-77. PubMed ID: 11792066
[TBL] [Abstract][Full Text] [Related]
20. CMV-infected kidney grafts drive the expansion of blood-borne CMV-specific T cells restricted by shared class I HLA molecules via presentation on donor cells.
Gatault P; Al-Hajj S; Noble J; Chevallier E; Piollet M; Forconi C; Gaudy-Graffin C; Thibault G; Miquelestorena-Standley E; Halimi JM; Büchler M; Lemoine R; Baron C
Am J Transplant; 2018 Aug; 18(8):1904-1913. PubMed ID: 29377506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
